Section Arrow
ZLAB.NASDAQ
- Zai Lab Limited
Quotes are at least 15-min delayed:2025/11/04 19:35 EST
After Hours
Last
 25.62
-0.27 (-1.04%)
Bid
25.6
Ask
26
High 26.19 
Low 25.6 
Volume 10429 
Regular Hours
Last
 25.89
-0.86 (-3.21%)
Day High 
26.255 
Prev. Close
26.75 
1-M High
34.06 
Volume 
921.73K 
Bid
25.6
Ask
26
Day Low
25.67 
Open
26.11 
1-M Low
25.13 
Market Cap 
2.98B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 26.81 
20-SMA 28.67 
50-SMA 30.94 
52-W High 44.34 
52-W Low 23.82 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.00/-0.24
Enterprise Value
2.99B
Balance Sheet
Book Value Per Share
7.12
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
398.99M
Operating Revenue Per Share
2.37
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
RXRXRecursion Pharmaceuticals5-0.44-8.09%-- 
After Hours 4.8999 -0.1001 -2.00%
RANIRani Therapeutics Holdings2.38+0.23+10.70%-- 
After Hours 2.41 +0.03 +1.26%
PRLDPrelude Therapeutics1.76-2.22-55.78%-- 
After Hours 1.68 -0.08 -4.55%
SRPTSarepta Therapeutics16.2-8.25-33.74%15.76PE
After Hours 16.15 -0.05 -0.31%
RLMDRelmada Therapeutics2.77+0.57+25.91%-- 
After Hours 2.63 -0.14 -5.05%
Quotes are at least 15-min delayed:2025/11/04 19:35 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.